Motor neuron disease as a treatment responsive paraneoplastic neurological syndrome in patient with small cell lung cancer, anti-Hu antibodies and limbic encephalitis

Non-classical paraneoplastic neurological syndrome (PNS) may be identified and classified as “definite” and “probable” according to the antineuronal antibodies status and the presence or absence of an associated cancer [1]. Paraneoplastic motor neuron disease (PMND) is a rare, potentially treatable, non-classical PNS that may be undistinguishable from sporadic motor neuron disease (MND) [2].

Source link

Related posts

Outcomes After Seizure Recurrence Upon AED Withdrawal Following Temporal Lobectomy


Study finds 117% increase in number of dementia sufferers in 26 years


Autonomic nervous system depression at term in neurologically normal premature infants.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy